Pharma Stocks Dip As Pfizer, Merck Sustain Unexpected FDA Rejections
- Oops!Something went wrong.Please try again later.
- Oops!Something went wrong.Please try again later.
- PFE
- OPK
Pfizer stock skidded Monday after the Food and Drug Administration rejected its rare-disease drug — leading a smaller decline for similarly jilted Merck.